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Npro fusion technology, a highly efﬁcient system for overexpression of proteins and peptides in Escher-
ichia coli, was further developed by splitting the autoprotease Npro into two fragments to generate a
functional complementation system. The size of the expression tag is thus reduced from 168 to 58 amino
acids, so by 66%. Upon complementation of the fragments auto-proteolytic activity is restored. This
process has been shown for three model proteins of different size, a short 16 aa-peptide, MCP-1, and
lysozyme. Moreover, the complementation was still functional after immobilization of the N-terminal
fragment to a solid support which enables recycling of the immobilized fragment. This strategy enhances
overall productivity of Npro Fusion Technology and thus allows more efﬁcient production of recombinant
proteins with reduced costs and in higher yields. Overall, the Npro complementation system has,
depending on the size of the target molecule, potential to increase the productivity up to 4 fold for batch
refolding and even more for on-column refolding strategies by the proven possibility of regeneration of
the immobilized fragment.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Npro Fusion Technology has been widely used to produce pro-
teins with an authentic N-terminus [1]. This technology for over-
expression of peptides and proteins in Escherichia coli utilizes the
autoprotease Npro derived from Pestiviruses as a self-cleaving
expression tag. Upon folding Npro releases the target with an
authentic N-terminus. The target therefore must be expressed as a
C-terminal fusion to the autoprotease. Deposition of such Npro
fusion proteins in inclusion bodies enables the production of het-
erologous protein of high yields and purity [2], facilitated down-
stream processing [3] and expression of small and toxic peptides
[4,5]. However, deposition in inclusion bodies requires solubiliza-
tion and refolding steps for recovery of functional products.gy, University of Natural Re-
Vienna, Austria.
rauer).
striestraße 67, 1221 Vienna,
10, 6250 Kundl, Austria.
Inc. This is an open access article uSolubilization of inclusion bodies is a crucial step, which needs
proper optimization of conditions to reach the highest possible
yields [6]. Refolding by rapid dilution into kosmotropic buffers
ﬁnally renders autoprotease Npro active to release the target protein
by one precise cut in the C-terminal at residue C168. Current Npro
Fusion Technology using the mutant EDDIE of the wild type auto-
protease designed by exchange of 11 amino acids (aa) exerts
improved cleavage. This improvement has been demonstrated for
pharmaceutically relevant targets [1,7] as well as for antimicrobial
peptides [8]. The major shortcoming of this expression tool is
overexpression of a tag 19 kDa in size. Reducing the size of the
expression tag by a complementation strategy will concomitantly
reduce production costs and increase overall expression perfor-
mance of Npro Fusion Technology. To reach this goal, we undertook
the design of Npro Fusion Technology as a complementation system.
The ability of protein fragments to reassemble through non-
covalent interactions into functional enzymes is possible and has
been shown for fragment-complementation of bovine pancreatic
ribonuclease [9], T-nuclease from Staphylococcus aureus [10], b-galac-
tosidase [11], dihydrofolate reductase [12], Renilla luciferase [13], and
proteins such as green ﬂuorescence protein and variants thereof [14].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
S. Schindler et al. / Protein Expression and Puriﬁcation 120 (2016) 42e50 43WeusedamutatedNpro variantof classical swine fever virus strain
Alfort, termed D21Npro 37. In this mutant the ﬁrst 21 residues of the
wild type sequence are deleted. Deletion of these 21 N-terminal
amino acids had no impact on proteolytic activity, but inhibited
interaction with the cellular immune system via interferon-
regulatory factor 3 which is important for production of bio-
pharmaceuticals [15,16]. Based on structural knowledge [17], we split
D21Npro37 into two parts: The N-terminal fragment was designed to
harbor the protease domain containing all catalytically important
residues, while the C-terminal fragment was fused to the target
molecule. We used three different targets ranging from 16 to 157
amino acids in length. All fragments as well as the full-length variant
were overexpressed in E. coli and mostly deposited as inclusion
bodies. Inclusionbodieswere solubilizedunderchaotropic conditions
and subsequently refolded by rapid dilution. Reassembly of the active
autoprotease Npro structure led to release of the targets.
The proof of principle for the complementation approach was
shown by utilizing three different targets: (1) pep6His, 16 amino
acids of randomized order with a C-terminal 6His-tag; (2) mono-
cyte chemoattractant protein MCP-1, a chemokine of therapeutic
interest, 79 amino acids in length; and (3) lysozyme with a C-ter-
minal 6His-tag and a molecular weight of 17.8 kDa. All subsequent
experiments to investigate the expression yield, ratio of soluble to
insoluble fractions of overexpressed fusion protein, solubilization
yield, and different refolding conditions and strategies during
complementation were carried out with pep6His as target, which
had shown the highest cleavage yield in the preliminary experi-
ments. All experiments were carried out in direct comparison to
results obtained for the full-length fusion protein of the same
target. In Fig. 1 the target release is schematically depicted
comparing a full-length fusion molecule (A) to the complementa-
tion set up (B).
Schmoeger et al. previously showed that contact with the chro-
matographic matrix enhanced the shift from aggregates to the in-
termediate or monomeric state and therefore promoted refolding
[18]. Therefore, our goal was to prove the applicability of our devel-
oped complementation system for on-column refolding (for sche-
matic depiction of target release see Fig.1C). Thismethodology holds
the potential for signiﬁcant further improvement since the immobi-
lization of one fragment to a stationary phasewill enable re-usage for
several cycles of cleavage. Therefore, we investigated the immobili-
zation of the GST-tagged N-terminal fragment by binding to
Glutathione-Sepharose afﬁnity resin, the cleavage yield, and the po-
tential for recycling of the immobilized fragment were investigated.
2. Material and methods
2.1. Cloning of constructs
2.1.1. Construct D21Npro37 was used as a template
Two N-terminal D21Npro37 D107-168 and three C-terminalFig. 1. Schematic depiction of Npro target liberation and the D21Npro37 complement
complementation system with the N- and C-terminal fragment used for off-column com
fragment used for on-column complementation by afﬁnity binding and corresponding C-term
solution after successful refolding/cleavage.fragments D112Npro37 were generated using corresponding
primers including appropriate restriction sites. For exchange of the
Npro sequence, restriction sites NdeI (50) and SpeI (30) were used.
After PCR ampliﬁcation DNA fragments were digested and one N-
terminal and three C-terminal inserts were subcloned into pET30a-
c(þ), an IPTG-inducible expression vector from Novagen based on
the pET expression. For the second N-terminal fragment, its
sequence was ampliﬁed by PCR and subcloned into pGEX-4T-2 (GE
Healthcare, Uppsala, Sweden) using restriction sites BamHI and
XhoI. pGEX-4T-2 provides the fusion protein with an N-terminal
GST-tag. After transformation of E.-coli NovaBlue (Novagen, Merck
Millipore, Billerica, MA, USA), all sequences were veriﬁed by
sequencing (MWG Euroﬁns). See Table 1 for all generated variants.
2.2. Protein expression and process analysis
Protein expression was performed using E. coli BL21(DE3)
(Novagen, Merck Millipore, Billerica, MA, USA) carrying the T7
polymerase gene for protein expression using the T7 promoter
[19,20]. An overview of the D21Npro37-pep6His reference full-
length fusion protein and the corresponding protein fragments
thereof used for the complementation system is listed in Table 1.
For the proof of concept experiments expression is performed in
laboratory scale: After transformation, overnight cultures were
diluted 1:100 and cells were grown in up to 400 mL of medium
(10 g peptone, 7 g yeast extract and 2.5 g NaCl per liter) at 37 C and
220 rpm. When an OD600 between 0.5 and 1.0 was reached,
expression was induced with 0.1 mM IPTG. After 2e4 h, cells were
collected by centrifugation and stored at20 C. Samples before (-I,
250 mL) and after induction (þI, 125 mL) were collected by centri-
fugation for SDS-PAGE analysis. For all further experiments and
investigation of optimal solubilization and refolding conditions,
expressions were performed in larger scale in a 10 L (5 L working
volume) computer-controlled bioreactor (MBR, Wetzikon, CH) as
described previously [20]. Optical density (OD) is measured at
600 nm. Bacterial dry matter was determined by centrifugation of
10 mL of the cell suspension, re-suspension in distilled water fol-
lowed by centrifugation, and re-suspension for transfer to a pre-
weighed beaker, which is then dried at 105 C for 24 h and re-
weighed. The progress of bacterial growth was determined by
calculating the total amount of biomass (total bacterial dry matter
BDM; also termed cell dry weight CDW). The evaluation of the
expressed fusion protein was performed with SDS-PAGE by means
of a linear regression curve of a puriﬁed EDDIE (autoprotease)
standard. Aliquots of 1 mg CDW of each fermentation broth were
harvested by centrifugation at 14,000 rpm for 10 min (Centrifuge
5415R, Eppendorf, Germany) and the supernatants were decanted.
Each pellet was resuspended in 200 mL lysis buffer (27 mM Tris/HCl,
pH ¼ 8.2, 25 mM EDTA, 10 mM MgCl2 x 6H20, 28.6 mM 2-
mercaptoethanol) and after rigid mixing 50 mL of a aqueous
2 mg/mL lysozyme stock solution and 50 mL of a benzonase stockation system. (A): D21Npro37 e full-length autoprotease as fusion tag; (B): Npro37
plementation; (C): Npro37 complementation system with the GST-tagged N-terminal
inal fragment fused to the target molecule. Left: Refolding set up; Right: Fragments in
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S. Schindler et al. / Protein Expression and Puriﬁcation 120 (2016) 42e5044solution (50 units/mL) were added and mixed vigorously. After
incubation for 10 min at RT with gentle mixing 100 mL Triton X-100
were added, incubated for 10 min at RT with gentle mixing. The
pellet was harvested by centrifugation for 10 min at 4 C at
14,000 rpm. Aliquots of the separated supernatants were analyzed
by SDS-PAGE and results are labeled as “SOL” e soluble fractions.
After two washing steps in 1 mL 30 mM Tris/HCl, pH 8.2 and sub-
sequent centrifugation for 10 min at 4 C at 15,000 rpm each IB
pellet was solubilized in 400 ml 8 M urea, 100 mM Tris/HCL, pH 8.2,
100 mM 2-mercaptoethanol. Aliquots of the IB solutions were
analyzed by SDS-PAGE and results are labeled as “IB” e insoluble
fractions. The protein content of bands was determined densito-
metrically by the ImageQuantTL Software.
2.3. Cell lysis and collection of inclusion bodies
For proof of concept experiments on laboratory scale, cell pellets
harvested from 400 mL shake ﬂask cultivations with of 60 to
maximum 80mg CDWwere resuspended in10 mL freshly prepared
lysis buffer (75 mM NaCl, 20 mM sodium phosphate, 5 mM EDTA,
2 mM MgCl2, pH 8.0) and lysed twice via French Press at 1200 psi.
Inclusion bodies were collected by centrifugation at 6000 g for
15 min at 4 C and stored at20 C. For all further experiments and
investigation of optimal solubilization and refolding conditions IBs
were derived from 10 L fermentations and were harvested and
prepared as described previously [21]. Brieﬂy, the cell pellet after
was re-suspended in 50 mM Tris, 50 mM NaCl, and 0.02% Tween at
pH 8.0 using an ultra turrax (IKA, Staufen, Germany) to obtain a dry
matter concentration of 30 g/L and afterwards passed twice
through a high pressure homogenizer (Panda 2K, GEA Niro Soavi
S.p.A., Parma, Italy). The separated IBs were washed twice in a
buffer containing 0.5 M NaCl (20 mM Tris, 0.5 M NaCl, and 0.02%
Tween at pH 8.0) and in the third step in the same buffer without
NaCl. The ﬁnal slurry contained 40% IBs in distilled water and was
stored at 20 C.
2.4. Solubilization of inclusion bodies
For proof of concept experiments, frozen inclusion bodies were
directly solubilized in 0.5e1 mL of phosphate solubilization buffer
(5 M GuHCl, 50 mM sodium phosphate, 100 mM NaCl, 10 mM
monothioglycerol (MTG); pH 7.5) and shaken at RT for 60e90 min.
Solubilization was stopped by centrifugation at 16,600 g for
10 min at RT (microfuge Sigma 1e14K). The insoluble fraction was
termed “IB”.
For all further experiments and investigation of solubilization
and refolding conditions, lyophilized IBs were resuspended 1:5 (w/
v) in water for 15 min at RT. The IB suspension was mixed with
either urea- or GuHCl-containing solubilization buffer to reach a
composition of 8 M urea, 20 mM Tris, 100 mM MTG or 5 M GuHCl,
20 mM Tris, 100 mM MTG, both at pH 7.5. Solubilization was per-
formed at low frequency shaking (end-over-end) for 60 min and
was stopped by centrifugation at 16,170 g at 21 C for 3 min
(Centrifuge 5415R, Eppendorf, Germany) and consecutive ﬁltration
through 0.22-mm ﬁlters (Merck Millipore, Billerica, MA, USA).
2.5. Puriﬁcation of inclusion bodies by Ni-NTA afﬁnity
chromatography
Inclusion bodies were puriﬁed by performing Ni-NTA chroma-
tography under denaturing conditions. Therefore, 0.5 mL of Ni-NTA
agarose (QIAGEN, NL) was equilibratedwith 5 column volumes (CV)
of the corresponding solubilization buffer. Imidazole (20 mM) was
added to the solubilizing buffer as well as to the IB solution prior
loading onto the column. After sample loading, the column was
S. Schindler et al. / Protein Expression and Puriﬁcation 120 (2016) 42e50 45washed with 5 CV of solubilization buffer containing 20 mM
imidazole. Elution of His-tagged proteins was carried out with 4 CV
of solubilizing buffer containing 300mM imidazole and collected in
0.5 mL fractions. Protein concentration was measured via absor-
bance at 280 nm using a Peqlab NanoDrop ND1000 spectropho-
tometer and the respective extinction coefﬁcients
(23,045 M1cm1 for the full-length autoprotease, 8940 M1cm1
for the N-terminus, 52,050 M1cm1 for the GST-tagged N-termi-
nus used for immobilization, 14,105 M1cm1 for C-terminus with
pep6His, 40,700 M1cm1 for C-terminus with lysozyme-6H and
22,835M1cm1 for C- terminus with MCP1 as target) as calculated
assumed to be measured in water at absorbance of 280 nm by
ProtParam [22]. Samples were collected throughout puriﬁcation
steps for analysis by SDS-PAGE.
2.6. Refolding/cleavage of the complementation system
2.6.1. Proof of concept refolding of the complementation system
For proof of concept off-column and on-column complemen-
tation experiments protein concentrations of inclusion body-
fractions were adjusted with solubilization buffer (5 M GuHCl,
50 mM sodium phosphate, 100 mM NaCl, 10 mM MTG; pH 7.5) to
the following values: N-terminal fragments were adjusted to 2 mg/
mL; C-lys6His to 2 mg/mL; C-MCP-1 to 1.5 mg/mL; and C-pep6His
to 1 mg/mL. Prior to refolding, equal volumes of these adjusted
protein solutions of each one N- and one C-terminal fragments
were combined. Subsequently, refolding and cleavage was started
by rapid dilution by 1:25 of these mixtures into phosphate
refolding buffer REF1 (50 mM sodium phosphate, 30% glycerol;
100 mM NaCl; 10 mM MTG, pH 7.0). Refolding/cleavage was left to
proceed statically for 60 h at RT. Then the refolding solution was
precipitated adding 25 ml of 100% TCA per 100 ml sample to a ﬁnal
TCA percentage of 20% (v/v) and the pellet was analyzed by SDS-
PAGE.
2.6.2. Refolding/cleavage of full-length variant and
complementation with pep6His as target
These experiments were always carried out with inclusion
bodies containing fusion protein of the full-length variant
D21Npro37-pep6His, the N-terminal fragmentD21Npro37 D107-168,
or the C-terminal fragments D112Npro37-pep6His in parallel.
Refolding/cleavage was started by rapid dilution into refolding
buffer. The experiments were carried out comparing three different
refolding buffers, namely REF1 as described above, REF2 (50 mM
(NH4)3PO4; 30% glycerol; 100 mM NaCl; 10 mM MTG, pH 7.0) and
REF3 (1 M Tris/HCl, 0.25 M sucrose, 2 mM EDTA, 10 mM MTG, pH
7.3) at ﬁnal protein concentrations ranging from 0.001 to 0.1 mg/
mL. For complementation, both fragments were, if not mentioned
otherwise, combined for refolding/cleavage in the molar ratio 1:1.
Two different strategies were followed for refolding/cleavage of the
complementation system (Fig. 2):
2.6.2.1. Method A (separate refolding of the complementation sys-
tem). After solubilization of the inclusion bodies in the corre-
sponding chaotropic buffer each fragment was separately diluted
1:20 into the refolding and solubilization buffer as a reference,
considering the required concentration as well as the IB impurities.
After 24 h of separate refolding, the fragment solutions were pooled
in the ratio 1:1 and incubated for another 24 h. Aliquots thereof
were analyzed by RP-HPLC to determine the corresponding cleav-
age yields.
2.6.2.2. Method B (combined refolding of the complementation sys-
tem). N- and C-terminal fragments were mixed in a molar ratio of
1:1 in solubilization buffer and rapidly diluted 1:20 into thecorresponding refolding buffer and into solubilization buffer as a
reference. After 24 h of refolding, aliquots were analyzed by RP-
HPLC to determine the cleavage yield.
2.7. On-column complementation
2.7.1. Preliminary experiments e refolding/cleavage of GST-tagged
N-terminal fragment
Maintaining the native structure of the Glutathione S-trans-
ferase (GST)-tagged N-terminal fragment is essential for afﬁnity
binding to Glutathione Sepharose 4B (GE Healthcare, Uppsala,
Sweden). The concentration of solubilized inclusion bodies was
adjusted to 1.3 mg/mL with 5 M GuHCl, 50 mM sodium phosphate,
100 mM NaCl, 10 mM MTG, pH 7.5. Refolding was performed in
phosphate refolding buffer REF1 by 1:25 dilution. Refoldingwas left
to proceed statically for 16 h at RT. Then soluble and insoluble
fractions of the refolding reactions were separated by centrifuga-
tion at 16,600 g for 10 min at RT (microfuge Sigma 1e14K). One
sample was precipitated with TCA for SDS-PAGE analysis.
2.7.2. On-column complementation and regeneration of
immobilized N-terminus
A portion (0.2 mL) of Glutathione Sepharose were equilibrated
and washed in a 5 mL-Eppendorf vial in accordance to the manu-
facturer's recommendations [23]. For immobilization, washed
Sepharose was incubated with 5 mL of the refolded GST-tagged N-
terminus at a concentration of 52 mg/mL. Incubationwas performed
with an end-over-end rotator for 120 min. After this incubation
step, Glutathione Sepharose was washed three times with 1 mL of
REF1. For each step fractions of 0.6 mL were collected, precipitated
with TCA, and analyzedwith SDS-PAGE. After immobilization of the
GST-tagged N-terminal fragment, the Glutathione Sepharose slurry
was incubated with 600 mL solubilized C-terminus, D112Npro37-
pep6His (3.90 mg/mL solubilized IBs diluted 1:25 in 50 mM
phosphate refolding buffer). On-column refolding was performed
at RTand end-over-end rotation for 60 h. Samples were analyzed by
SDS-PAGE and RP-HPLC to determine the corresponding cleavage
yield. For the recycling experiments, the Glutathione Sepharose
with the immobilized-N-terminus was washed three times with
1 mL of REF1 containing 0.05% sodium azide prior to the second
incubation with 1200 mL of freshly solubilized C-terminal fragment
(4 mg/mL solubilized IBs diluted 1:25 in phosphate refolding buffer
containing 0.05% sodium azide) for another 60 h at RT. Aliquots of
all steps during on-column refolding were taken and TCA pre-
cipitates thereof were analyzed by SDS-PAGE.
2.8. Analysis of cleavage and refolding yield
2.8.1. RP-HPLC analysis
Analyses of the cleavage yield were carried out by RP-HPLC as
described previously [21]. The cleaved target peptide (pep6His)
was quantiﬁed via calibration of the RP-HPLC with synthesized
pep6His. The concentration of fusion protein used (D21Npro37-
pep6His full-length or C-terminal fragment) was determined by
absorbance measurement at OD260/280. The maximum achievable
yield of the targetmoleculewas given by themolar ratio of target to
tag in the fusion protein multiplied by the protein concentration.
The actual cleavage yield was calculated by determining the
amount of cleaved pep6His determined by RP-HPLC analyses and
expressing this value as a percentage of the maximum available
amount of pep6His within the fusion protein.
2.8.2. SDS-PAGE analysis
For SDS-PAGE, the NuPage System fromNovagen in combination
with Bis-Tris gradient gels was used. Liquid samples were supplied
Fig. 2. Schematic overview of the entire workﬂow for the different approaches of the complementation system. (A) Separate; (B) combined refolding/cleavage of the
complementation system; and (C) on-column refolding/cleavage of complementation system after immobilization of the GST tagged N-terminal fragment to Glutathione Sepharose
by afﬁnity binding.
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8% (w/v) SDS, 400 mM b-mercaptoethanol, 0.004% (w/v) brom-
phenol blue) and run in running buffer (0.3% (w/v) Tris, 1.5% (w/v)
glycine, 0.1% (w/v) SDS). Precipitated protein samples and cell
pellets were dissolved in 60 mL 1x LDS buffer (Novagen, Merck
Millipore, Billerica, MA, USA), cell pellets were ultrasonicated.
Samples were heated to 95 C at 1400 rpm for 10 min and centri-
fuged again (2 min, 20,880 g, at 20 C, Centrifuge 5415R, Eppendorf,
Germany). Gels were loaded with marker (PageRuler prestained,
Fermentas; Mark12 Unstained Standard, Life Technologies, Carls-
bad, CA, USA) and 10 mL of each sample. Gels were run at
150e200 V.Fig. 3. Expression of Npro-fusion proteins for complementation system. SDS-PAGE
of soluble and insoluble (IBs) fractions overexpressed in E. coli BL21(D3) 3 h after in-
duction (20 mM IPTG/g CDM). M, Molecular weight marker; Standard 1e3, autopro-
tease standard of decreasing concentration; N-terminus, D21Npro37-6H D107-168;
C-terminus, D112Npro37-pep6His; Full-length, Fusion protein with full-length auto-
protease as tag, D21Npro37-pep6His; Sol, soluble fraction; IB, insoluble fraction; same
amounts of cell dry mass were applied for all samples; indicated lysozyme band in all
samples derives from cell lysis by lysozyme digest.3. Results and discussion
3.1. Expression yields of full-length fusion protein and fragments for
complementation system
All fragments of the D21Npro37 complementation system, two
N-terminal and three C-terminal (Table 1), were expressed in E. coli
BL21(DE3). Fig. 3 shows the results for overexpression of full-length
and the two complementation fragments for pep6His as target
exemplarily. All three fermentations reached the same growth of
23e26 g CDM/L. The overall expression rate of recombinant protein
related to overall protein was the highest for the C-terminus with
220 mg/g and 90% thereof were deposited as inclusion bodies. In
contrast, the N-terminus could only be expressed up to 20mg/g and
with 75% dominantly in the soluble fraction. 80% of the entire
160 mg/g full-length protein were deposited as inclusion bodies
and only here in vivo cleavage could be determined. Up to 20% of
the soluble expressed full length protein and 7% of the corre-
sponding inclusion bodies contained the autoprotease without
target indicating in vivo cleavage and it has to be taken into
consideration that this fraction of the expressed protein will not
contribute to the yield of producible target pep6His.3.2. Off-column complementation of D21Npro37
Inclusion bodies of both fragments, and the full-length fusion
protein were harvested. They were solubilized in 5 M GuHCl and
puriﬁed by Ni-NTA chromatography to obtain fragments of equal
purity for the complementation experiments. The C-terminal
fragment with target MCP-1 was used as it was expressed. The
protein concentrations of the eluted fractions were adjusted to
2mg/mL for N-terminal and to 4mg/mL for C-terminal fragments if
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1:25 into phosphate refolding buffer REF1. In previous small-scale
buffer screenings, this refolding buffer had shown the highest
cleavage yields for the Npro37 complementation systemwith target
pep6His (data not shown). Thus, there is a residual GuHCl-
concentration of 0.2 M in the refolding solutions. This concentra-
tion should be well below the reported refolding-interrupting
concentrations of denaturing agents, 0.5 M for GuHCl [24] and
0.5e1 M for urea depending on the target [25]. The cleavage yields
of this ﬁrst complementation experiments were analyzed by SDS-
PAGE (Fig. 4A). Clear bands were visible for the cleaved C-termi-
nus as well as for all three targets e lysozyme (lys6His), MCP-1 and
pep6His e for the D21Npro37 complementation system. Refolding
of the fragments, their correct complementation and subsequent
cleavage are distinct processes, which cannot be separately deter-
mined. Assuming that only correct refolding leads to complemen-
tation of the fragments and thus to cleavage activity, the cleavage
yield is a measure for the overall process. Therefore, we evaluated
the successful refolding and complementation via the determined
cleavage yield for all further analyses.
For the GST-tagged N-terminal fragment, which was intended
for use in on-column refolding, cleavage rates in solution were
much lower compared to the standard N-terminal fragment
(Fig. 4B). While no cleavage could be observed for the lys6His and
MCP-1 fusions as targets (not shown), a moderate cleavage ratewas
determined for pep6His as target. This difference in performance
between the untagged and the GST-tagged N-terminus can arise
from the relatively large size and bulkiness of GSTor from the lower
ratio between tag and target. When compared to untagged stan-
dard N-terminal fragment (10.5 kDa), the four-fold lower molar
amount of GST-taggedN-terminal fragment (36.8 kDa) was used for
complementation experiments due to the large size difference. The
difference in cleavage rates of the three different C-terminal vari-
ants followed our expectations: the bigger in size, the lower
cleavage rates of the targets. Pep6His, the smallest target carryingFig. 4. Proof of principle for off-column and on-column complementation experiments
untagged N-terminal fragment with C-terminal fragments of the three targets lys6His, MCP-1
N-terminal fragment with the C-terminal fragment of the target pep6His. M, Molecular w
R, Cleavage after complementation for 60 h; asterisks indicate contaminating proteins co-
Glutathione Sepharose and are therefore not relevant for the subsequent on-column experthe native serine in post-cleavage position 169, clearly showed
cleavability while MCP-1 and lys6His as much larger targets were
not cleaved under the conditions chosen for this experimental
setup (not shown). In this case, differences in cleavage rates were
not expected to arise from the nature of the amino acid at position
169, which is known to affect cleavability. Methionine (lys6His) as
well as glycine (MCP-1) should even lead to higher in vitro cleavage
rates in position 169 compared to native serine, as was tested with
pep6His carrying all 20 canonical amino acids in position 169 [1].
After these ﬁrst proof-of-concept experiments, all further in-
vestigations were performed in a different way. Variants were
expressed in larger scale and optimal inclusion body solubilization
and refolding conditions were examined, comparing different
buffers. Because the best cleavage results were achieved with
pep6His, this target was chosen for all further investigations.3.3. Off-column complementation e inﬂuence of solubilization and
refolding buffer
We compared the cleavage performance of D21Npro37-pep6His
to two complementation experiments (Fig. 1): in method A each
fragment was refolded separately for 24 h and then mixed with the
other fragment for another 24 h, while in method B the denatured
fragments were together diluted into the refolding buffers and
cleavage yield analyzed after 24 h.
The resulting cleavage yields of the full-length fusion protein
compared to the two complementation approaches in three
refolding buffers after solubilization in 8 M urea are shown in
Fig. 5A, while cleavage yields after solubilization in 5 M GuHCl in
the corresponding buffers are shown in Fig. 5B. A strong de-
pendency of the cleavage yield on the solubilization conditions was
determined for the full-length fusion as well as for the comple-
mentation approach. While the cleavage yields for the full-length
fusion after solubilization in 5 M GuHCl ranged between
63 ± 0.9% in REF3 to 75 ± 1% in REF2, the corresponding cleavageby SDS-PAGE analysis. (A) Off-column complementation experiments by refolding of
and pep6His. (B) Off-column complementation experiment by refolding of GST-tagged
eight marker; R0, mixture of solubilized N- and C-terminal fragment, prior refolding;
purifying with the GST fusion on the Ni-NTA column, but which show no afﬁnity to
iments.
Fig. 5. Cleavage yield of fusion proteins with full-length autoprotease (FL) compared to complementation experiments with pep6His as target. Comparison of three different
refolding buffers REF1 (sodium phosphate/glycerol), REF2 (ammonium phosphate/glycerol) and REF3 (Tris/sucrose) obtained after solubilization of inclusion bodies in (A) 8 M urea
or in (B) 5 M GuHCl. Analyses were carried out with RP-HPLC determining the cleavage yield as ratio of cleaved target pep6His to maximum available target present in the fusion
protein.
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tendency of higher cleavage yield after solubilization in 5 M GuHCl
compared to 8 M urea was determined for the complementation
system, no matter which approach had been applied, but with
signiﬁcantly lower cleavage yields compared to the full-length
fusion protein. The highest cleavage yield of 34 ± 0.6% deter-
mined for the complementation system was obtained by direct
dilution of both fragments into REF1, the refolding buffer contain-
ing sodium phosphate and glycerol after solubilization in 5 M
GuHCl. Overall, the cleavage yields detected for the complemen-
tation approaches reached only 25e50% of the highest yields ob-
tained for the full-length fusion protein under the same conditions.
Based on the experimentally obtained results of expression
yields of the N- and C-terminal fragments compared to the full-
length fusion protein D21Npro37-pep6His and the determined
cleavage rates, the maximum possible yield was calculated (see
Table 2). In the full-length fusion protein, the autoprotease repre-
sents 148 amino acids of the total 164 amino acids. Thus, theoret-
ically only 10% of the overexpressed protein can be recovered as
target. While when the tag is cut at the C-terminal fragment, 22% of
the overexpressed protein can be theoretically recovered as theTable 2
Calculation of target yield obtainable from Npro 37 full-length fusion compared to the com
numbers for expression and cleavage yield for MCP-1 and lysozyme are hypothetically a
Peptide pep6His
N term C Term Full-len
Yield of recombinant protein overall [mg/g]
20
220 160
Yield of recombinant protein soluble [mg/g]
15
22 40
Yield of recombinant protein insoluble [mg/g]
5
198 120
Amino acid number tag
84
57 168
Amino acid number target
0
16 16
Amino acid fusion protein 73 184
Ratio target in recombinant protein
0
0.2 0.1
Maximum yield of target soluble [mg/g]
15
4.8 3.5
Maximum yield of target insoluble [mg/g]
5
43.4 10.4
Cleavage yield [%] 75 75
Overall yield of target protein [mg/g] 32.5 7.8
Ratio yield complementation system/full-length
for same cleavage yield
4.2
Ratio yield complementation system/full-length
for half cleavage yield in complementation
2.1target pep6His. If the target can be recovered from the inclusion
bodies, 3.7 times greater yield of pep6His could be obtained from
the C-terminal fragment compared to the full-length fusion. The
theoretical calculation is based on the same cleavage yield for the
full-length and the complementation system. For calculations tak-
ing into account half of the cleavage rate for the complementation
system compared to the full-length, only twice the yield of the
target molecule could be obtained by the complementation system.
This means that even with the highest cleavage yield of 34%, as
determined for off-column complementation compared to the
reference full-length variant D21Npro37-pep6His with up to 75%,
the complementation system exceeded the full-length system by
1.5 fold. In Table 2, column 5e10, the same calculations are shown
for MCP-1 and lysozyme as targets, assuming the same expression
and cleavage yields as determined for pep6His. These results clearly
show that the smaller the target protein, the greater is the potential
of the complementation system.
A second limitation must be taken into account for the evalua-
tion of the off-column complementation system, namely the low
expression yield for the N-terminal fragment, approximately one
tenth of the expressed C-terminal and the predominant proteinplementation system; numbers for pep6His are determined by experiments, while
ssumed the same as for pep6His for better comparability.
Peptide MCP-1 Protein lysozyme
gth N term C Term Full-length N term C Term Full-length
20 220 160 20 220 160
15 22 40 15 22 40
5 198 120 5 198 120
84 57 168 84 57 168
0 76 76 0 150 150
133 244 207 318
0 0.6 0.3 0 0.7 0.5
15.0 12.6 12.5 15.0 15.9 18.9
5.0 113.1 37.4 5.0 143.5 56.6
75 75 75 75
84.9 28.0 107.6 42.5
3.0 2.5
1.5 1.3
Fig. 6. Proof-of-principle on-column complementation experiments by SDS-PAGE
analysis. On-column refolding and recycling of GST-tagged N-terminal fragment
D21Npro37-6H D107-168 immobilized to Glutathione Sepharose with the C-terminal
fragment D112Npro37-pep6His. M, Molecular weight marker; R0, Mixture of solubilized
N- and C-terminal fragments, prior to refolding; R, Cleavage after complementation for
60 h; ocr1,On-column refolding experiment; FT, Flow through; W, wash; ocr2, On-
column refolding after washing the immobilized N-terminus e recycling; E, Elution
of N-terminus from Glutathione Sepharose. For ocr2, twice as much C-terminal frag-
ment was used compared to ocr1.
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ratio of 1:1 of both fragments for a successful complementation and
with no further optimization of the fermentation, this outcome
indicated the need of 3e8 fermentations of N-terminal fragment
per single fermentation of C-terminal fragment, depending on the
source (soluble or IBs) used for the recovery of the N-terminal
fragment.
3.4. On-column refolding
For on-column refolding and complementation, one of the two
Npro37 fragments must be bound to a solid support. This procedure
can either be accomplished by covalent immobilization or by
afﬁnity-binding. A GST-tagged N-terminal fragment allowed bind-
ing to Glutathione Sepharose. Two cycles of refolding were per-
formed under non-eluting conditions: a 1st on-column refolding
cycle followed by a 2nd one to check for possible recycling of the
immobilized N-terminus.
Afﬁnity binding of the GST-tagged N-terminal fragment to
Glutathione Sepharose was only possible under native conditions.
Therefore, inclusion bodies of the GST-tagged N-terminal fragment
were solubilized and puriﬁed by Ni-NTA chromatography. After
refolding, only half of the protein remained in solution and the
soluble fraction was further used for afﬁnity binding of refolded
GST-tagged N-terminal fragment to Glutathione Sepharose. After
binding, the 1st cycle of on-column refolding was performed: the
solid support with the immobilized N-terminus was incubated
with a 1.6 M excess of C-terminal fragment for 60 h at RT and end-
over-end rotation, to verify the saturation of the immobilized N-
terminus. In parallel and under the same conditions, one control
samplewas refolded, but with both fragments in solution. After this
ﬁrst incubation, the Glutathione Sepharose with the N-terminal
fragment still bound was then washed with refolding buffer.
Thereafter the 2nd cycle of refolding was performed with a 3 fold
molar excess of freshly dissolved C-terminal fragment. After the
recycling experiment, the bound GST-tagged N-terminal sample
was eluted from Glutathione Sepharose to prove speciﬁc binding.
All collected samples of the puriﬁcation, on-column refolding as
well as recycling supernatant and elution fractions were then
analyzed by SDS-PAGE (Fig. 6).
There were clear cleavage bands visible for the on-column
refolding (lane ocr1) as well as the recycling supernatant (lane
ocr2). For ocr1, a cleavage rate of 18% was determined by RP-HPLC
via amount of peptide pep6His. It can be estimated from SDS-PAGE
that cleavage rates are the same for the ﬁrst and the second use of
the N-terminal fragment. This lower cleavage yield obtained for the
on-column mode compared to the 35% determined for the batch-
mode complementation can be caused by the steric hindrance
that can occur due to the large binding partner GST of the N-ter-
minus. Additionally, as GST forms dimers already the misfolding of
only one GST might inﬂuence the proper folding of the N-terminus
and therefore inhibit its cleaving activity. Improving the immobi-
lization technique has high potential for optimization for the on-
column complementation.
For the recycling experiment termed ocr2, twice as much of the
C-terminal fragment was used for on-column refolding, thus the
bands are twice as dense compared to ocr1. Interestingly, most of
the cleaved C-terminal fragment is contained within the superna-
tant and only part of it is bound to the N-terminal fragment as it
was proposed after structure determination: Npro should act only
once in cis fashion, meaning intramolecular cleavage, because the
substrate strand would remain trapped within the active site
[16,26]. This part of cleaved and trapped C-terminus seems to come
off the column during the intermediate washing steps which is
indicated by the decreasing content of C-terminus in lane W1 toW3. More dominant is the presence of uncleaved C-terminus-
pep6His in the washing steps (laneW1 toW3) which indicates that
the C-terminus with the target is more strongly bound to the N-
terminus until cleavagewhile the cleaved C-terminus is released. In
addition, since only 26% of the theoretical total binding capacity of
Glutathione Sepharose is occupied by immobilized N-terminus
uncleaved C-terminus might unspeciﬁcally bind to the “free” resin
and come off during the washing steps. This could be reduced by
immobilizing GST-tagged protein in concentrations close to the
total binding capacity of the resin.
In the elution fractions (lanes E1 and E2) there is one prominent
band of the right size for GST-tagged N-terminal fragment at
37 kDa, an observation that conﬁrmed speciﬁc binding of the N-
terminal fragment. All other impurities of smaller size within the
Ni-NTA fraction puriﬁed fromGST-fusion IBs are of unknown origin,
but as can be seen in elution fractions E1 and E2, they do not bind to
Glutathione Sepharose. Most probably, the GST-Npro fusion protein
was partially degraded during expression.
4. Conclusion
The complementation system gives a competitive edge espe-
cially for recombinant production of peptides and small proteins.
This advantage is obtained by the 66% reduction in size of the C-
terminal fragment which is directly fused to the N-terminus of the
target protein. Up to 3.7-fold higher yield of target can be obtained
because the size of the tag and the target protein is smaller
compared to the full-length construct. This expectation has been
conﬁrmed for the target peptide pep6His. The low cleavage yield of
the complementation system and the low expression yield of the N-
terminal fragment was overcome by on-column refolding by
passing the truncated autoprotease over a column with immobi-
lized N-terminal fragment. We have demonstrated that on-column
refolding of the complementation system leads to 18% cleavage
yield which was constant for at least two cycles of regeneration.
With this recyclable N-terminal fragment, only themuch smaller C-
terminal fragment-fusion must be expressed for the individual
S. Schindler et al. / Protein Expression and Puriﬁcation 120 (2016) 42e5050target molecules. Despite the lower cleavage yields of the
complementation setup compared to full-length autoprotease, the
complementation system has advantages regarding productivity
especially when it is used in the on-column refolding operation.
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